Notably, this gastric emptying delay is most pronounced after the first dose and tends to diminish with continued use
The development of stable, long-acting GLP-1RAs marks significant advancement, positioning these agents at the forefront of translational research across multiple disease domains
Retatrutide is a novel triple receptor agonist (GLP-1, GIP, and glucagon receptor) currently under Phase III clinical investigation for metabolic research applications
Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice
In ovariectomized rats, it significantly lowered serum cholesterol and triglyceride levels
For many, the biggest change isnt just the physical result